The company's lead drug candidate just received some bad news from the FDA.
News & Analysis: Ampio Pharmaceuticals
What goes up must come down.
An important industry analyst has little hope for the tiny company.
The small-cap biopharma stock has exploded at the end of 2017.
These five stocks posted double-digit percentage gains.
February's over -- and investors of these horrendous health-care stocks of the week just might be saying "good riddance." Here's why.
Alexion Pharmaceuticals, Salix Pharmaceuticals, and Ampio Pharmaceuticals could all make health-care headlines this morning.
What three factors will impact Ampio the most in 2014, and how will other companies, such as Roche, Novartis, and Regeneron, be affected?
Keep an eye on Dendreon, Zogenix, and Ampio -- they could make big moves during today's trading.
Investors want Ampio to show them the money, and Ampio happily obliges!